Proposing new lipoprotein (a) cut off value for Kazakhstan: pilot study
IntroductionThere is no consensus on the optimal concentration of lipoprotein(a) (Lp(a)) for the risk of atherosclerotic cardiovascular diseases (ASCVD) and aortic valve stenosis. In various clinical guidelines and agreed documents, the threshold level of Lp (a) is 30 mg/dl or 50 mg/dl. We estimated...
Na minha lista:
| Principais autores: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2024-10-01
|
| coleção: | Frontiers in Cardiovascular Medicine |
| Assuntos: | |
| Acesso em linha: | https://www.frontiersin.org/articles/10.3389/fcvm.2024.1468566/full |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|
